- Change in Alzheimer’s Drug Vial Size Could Be Big Money-Saver for Medicare
- GLP-1 Weight-Loss Meds Won’t Raise Teens’ Suicide Risk, May Even Lower It
- Most ERs Not Fully Equipped to Treat Pediatric Patients
- 1 in 4 U.S. Adults Suspect They Have Undiagnosed ADHD
- Ozempic Plus Intestinal ‘Zap’ Therapy May Eliminate Need for Insulin in Type 2 Diabetics
- More Bystanders Are Using Naloxone to Save Folks From Overdose
- A Boozy Night Out Could Upset Your Heart’s Rhythm
- Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
- Long-Term Care Out of Reach for 6.5 Million ‘Near Dual’ American Seniors
- Learn Another Language to Boost Your Brain’s ‘Efficiency’
All posts by LadyLively
-
Experimental Treatment Offers New Hope Against Lupus
An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of...
- Posted May 27, 2021
-
AHA News: College Kid Couldn’t Shake Headache – Until Other Symptoms Revealed a Stroke
THURSDAY, May 27, 2021 (American Heart Association News) — Soon after turning 21, Jacob York and his buddies from the University of Missouri were in Miami Beach, Florida, for spring break. They spent their days by the...
- Posted May 27, 2021
-
AHA News: Deep Disparities Persist in Who Gets Exposed to Secondhand Smoke
THURSDAY, May 27, 2021 (American Heart Association News) — Harmful secondhand tobacco smoke remains more widespread than most people think, experts say, and exposure is particularly high for children, Black adults and people living below the poverty...
- Posted May 27, 2021
-
FDA Approves Third COVID Antibody Treatment for Emergency Use
A third antibody treatment designed to keep high-risk COVID-19 patients from winding up in the hospital was approved for emergency use by the U.S. Food and Drug Administration on Wednesday. Importantly, in lab tests the newly authorized...
- Posted May 27, 2021
-
Health Highlights: May 27, 2021
COVID-19 Vaccines May Give Protection for Years: Studies COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime to people who were previously exposed to the virus, two new studies suggest. Both...
- Posted May 27, 2021
-
Many Pre-Surgery Tests Are Useless, So Why Are Hospitals Still Using Them?
Patients facing relatively simple outpatient surgeries are nonetheless being told to undergo a number of preoperative tests that just aren’t necessary, a new study reports. More than half of a group of patients facing low-risk outpatient surgery...
- Posted May 27, 2021
-
Your City Has Its Own Microbial ‘Signature,’ Scientists Say
Each city has its individual mix of tell-tale microbes, new research shows. “If you gave me your shoe, I could tell you with about 90% accuracy the city in the world from which you came,” said study...
- Posted May 27, 2021
-
Global Warming Could Bring More Stillbirths, Study Warns
Rising temperatures caused by climate change could trigger a worldwide increase in stillbirths, researchers warn. The team at the University of Queensland in Australia analyzed 12 studies on the subject. They found that exposure to extremely high...
- Posted May 27, 2021
-
There’s Been a Shift in Who’s Funding Alzheimer’s Research
The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer’s disease research, two new studies show. The findings are from an analysis of national data by Jeffrey Cummings, a research professor at...
- Posted May 27, 2021
-
Did a Ban on Flavored Vapes Raise Teen Smoking Rates?
A ban on flavored vaping products in San Francisco may have increased high school students’ use of conventional cigarettes, according to a new study. In 2018, voters in the city overwhelmingly approved a ballot measure banning the...
- Posted May 27, 2021